Amolyt Pharma
Multinational group of biopharmaceutical companies developing drugs, proteins and peptides.
Launch date
Employees
Market cap
-
Enterprise valuation
€502—753m (Dealroom.co estimates Jan 2023.)
Company register number 803919729
Écully Auvergne-Rhône-Alpes (HQ)
Financials
Estimates*
| EUR | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 |
|---|---|---|---|---|---|---|
| Revenues | <1m | - | - | <1m | <1m | <1m |
| % growth | - | - | - | - | 155 % | (47 %) |
| Profit | (<1m) | (<1m) | (<1m) | (3.7m) | (11.1m) | (18.0m) |
| % profit margin | (24165 %) | - | - | (91857 %) | (107800 %) | (327471 %) |
| Date | Investors | Amount | Round |
|---|---|---|---|
| N/A | €3.3m | Seed | |
€5.0m | Series A | ||
€1.8m | Late VC | ||
N/A | Acquisition | ||
* | €67.0m | Series A | |
* | $80.0m | Series B | |
* | $138m | Series C | |
* | $800m | Acquisition | |
| Total Funding | €275m | ||
Related Content
Recent News about Amolyt Pharma
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.